Delivery Order 75N92020D00022-75N93021F00034

This contract is for ILLUMINA REAGENTS AND CONSUMABLES, awarded to Illumina, Inc., a biotechnology company specializing in genetic sequencing and genomic analysis technologies. The $19,715.78 firm-fixed-price delivery order was awarded by the National Heart Lung and Blood Institute, a civilian agency within the U.S. Department of Health and Human Services. The contract has an ultimate completion date of December 9, 2019 and was not set aside for any specific business category. Illumina, Inc....

This is a firm fixed-price delivery order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the Department of Health and Human Services, to Illumina, Inc., a manufacturer of genomic sequencing and analysis instruments and reagents. The contract is for the procurement of reagents and consumables for AMBIS (HHSN268201500004I|HHSN27200044) and has a ceiling value of $133,620.00. The contract has no set-aside designation and was awarded on a...

This is a firm fixed price delivery order contract awarded by the Department of Health and Human Services' National Institutes of Health National Cancer Institute to Illumina, Inc., a manufacturer of genomic sequencing instruments and consumables. The $228,009.60 contract is for the provision of reagents and consumables, with no set-aside designation. Illumina is a manufacturer of sequencing systems like the NextSeq, NovaSeq, MiSeq, and iSeq, and has previously provided these platforms and...

This is a delivery order for REAGENT (CHEMISTRY) KITS awarded to Illumina, Inc., a for-profit manufacturer of sequencing and genomic analysis solutions. The $60,125.97 firm fixed price award is from the Department of Health and Human Services Food and Drug Administration, and does not have a set-aside designation. Illumina has a history of providing sequencing systems, reagents, and related analytical products and services to support genomics research and diagnostics across various federal...

This firm-fixed-price delivery order was awarded by the Department of Health and Human Services' National Institutes of Health National Institute on Aging to Illumina, Inc., a manufacturer of sequencing and array-based analytical instruments and reagents. The $227,174.40 contract is for the provision of reagents and consumables to support genomic research and analysis. Illumina has previously been awarded prime federal contracts by agencies such as the National Institutes of Health, Centers...

The National Institutes of Health National Heart Lung and Blood Institute awarded a $591,721.73 firm fixed price delivery order contract to Illumina, Inc. of San Diego, California. The contract is for Illumina Reagents and Consumables and has a period of performance from September 21, 2022 through September 27, 2023. Illumina will provide reagents and consumables, which are materials used in biological and medical research and testing, to support the research efforts of the funding agency. No...

This is a firm fixed-price delivery order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to Illumina, Inc., a manufacturer of genetic sequencing equipment and consumables. The $12,602.30 award is for the supply of an AMBIS 1696373 MouseWG-6 V2.0 Expression BeadChip Kit, which provides 36 sample processing capacity. The award has no set-aside designation. Illumina has a history of providing sequencing systems,...

This is a firm fixed price delivery order contract awarded by the Department of Health and Human Services Food and Drug Administration to Illumina, Inc. for the provision of reagent (chemistry) kits. The contract has a potential value of $360,184.83 and a completion date of September 14, 2022. Illumina, Inc. is a for-profit manufacturer of goods that specializes in sequencing and array-based solutions for genetic and genomic analysis. Through past prime federal contract awards, Illumina has...

The Department of Health and Human Services Centers for Disease Control and Prevention awarded a firm fixed price Blanket Purchase Agreement (BPA) call to Illumina, Inc., a manufacturer of genetic and genomic analysis instruments and reagents. The $106,034.28 contract is for the delivery of REAGENT KIT products, with a completion date of September 1, 2021. Illumina, a for-profit organization and manufacturer, has previously provided sequencing systems, reagents, and related services to support...

This is a firm fixed price delivery order awarded by the Food and Drug Administration (FDA), a civilian agency, to Illumina, Inc., a for-profit manufacturer of sequencing and genomic analysis instruments and reagents. The contract, valued at $277,984.22, is for the provision of REAGENT (CHEMISTRY) KITS with a period of performance through September 30, 2022. There is no set-aside designation noted. Based on Illumina's background as a provider of genomic sequencing systems and consumables to...